Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

S&P 500 Stumbles as Tech, Inflation Jitters Offset Earnings Euphoria

Published 14/04/2021, 20:37
Updated 14/04/2021, 21:07
© Reuters.

By Yasin Ebrahim

Investing.com – The S&P 500 closed lower Wednesday, as the Fed's Beige Book report stoked inflation jitters somewhat offsetting intraday optimism following earnings from Wall Street banks that topped estimates.

The S&P 500 fell 0.4%, after hitting a record intraday high of 4,151.97, the Dow Jones Industrial Average rose 0.16%, or 54 points, but had hit a record of 33,911.25, and the Nasdaq Composite was off 0.99%.

Many districts reported moderate price increases, with some saying prices rose more robustly, according to the Fed's Beige Book report. "Contacts generally expect continued price increases in the near term."

Still, many are betting that bullish quarterly earnings will sustain bullish bets on the broader market.    

JPMorgan (NYSE:JPM),Goldman Sachs (NYSE:GS) and Wells Fargo (NYSE:WFC) reported results that beat on both top and bottom lines.

Goldman Sachs was the standout performer as first-quarter earnings of $18.60 a share came in well above estimates of $10.19 a share, led by record investment banking revenue and a jump in trading revenue.

Goldman Sachs' Q1 performance was "very strong," and showed "remarkable revenue generation," UBS said.

Bed Bath & Beyond (NASDAQ:BBBY), meanwhile, reported earnings that topped estimates, but a 16% decline in sales and softer guidance pressured its shares to fall 12%.

“The co. highlighted continued positive trends in 1Q QTD. Still, its 1Q sales guidance of 40% is below the cons. of 46%,” UBS said.

Beyond earnings, Moderna (NASDAQ:MRNA) delivered a positive update on its vaccine, easing some of the concern following the Johnson & Johnson (NYSE:JNJ) vaccine setback on Tuesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moderna said late-Tuesday that new data show its vaccine is more than 90% effective six months after the second shot, sending its shares nearly 7% higher.

Energy, meanwhile, followed oil prices higher as data showed U.S. crude inventories fell more than expected, stoking optimism that energy demand remains firm.

U.S. crude oil stocks fell by 6 million barrels, well above the 2.9 million barrel decline expected.

Technology stuttered following its run higher as rising bond yields, which had weighed on growth stocks, appears to be running out of steam.

Google-parent Alphabet (NASDAQ:GOOGL), Apple (NASDAQ:AAPL), Facebook (NASDAQ:FB) and Amazon.com (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT), the so-called Fab 5, were lower.

In other news, Coinbase Global (NASDAQ:COIN) ended up 31% higher after making its public market debut through a direct listing at $381 per share, up from the reference price of $250.  

Coinbase's current business model has come under security amid concerns that increased competition will eventually cut into the company's high trading fees, which make up more than 90% of revenue.

But Coinbase CEO Brian Armstrong has suggested the company is investing in other business streams to generate more stable revenue that could eventually make up about half of total revenue, easing the reliance on trading fees.  

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.